Drug intelligence / Profile preview

TLC VITA

Development stage
Unknown
Lead developer
Remed Pharmaceuticals
Modality
Peptides, Small Molecules, Recombinant Proteins and Enzymes
Administration
Oral
01

Overview

TLC VITA is a comprehensive nutritional supplement developed by Remed Pharmaceuticals, Inc. and manufactured by Lloyd Laboratories, Inc. in the Philippines. It is formulated as a combination of essential vitamins and minerals, further enriched with taurine, lysine, and Chlorella Growth Factor (CGF). The supplement is designed to address micronutrient deficiencies and provide general nutritional support, particularly to aid in the growth and development of pediatric populations. It is available in various oral forms, including capsules, syrup, and drops. The mechanism of action involves the replenishment of essential vitamins and minerals required for various metabolic processes, while the additional components like lysine and taurine support protein synthesis and neurological health, and CGF is intended to promote cellular repair and growth.

Brand names
TLC VITA
Other names
Vitamins + Minerals with Taurine, Lysine and Chlorella Growth Factor

Beyond the preview

Go deeper on TLC VITA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TLC VITA.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call